Overview

Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Status:
Unknown status
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of fluphenazine in patients with advanced multiple myeloma. The study will also describe the efficacy of this drug.
Phase:
Phase 1
Details
Lead Sponsor:
Immune Control
Treatments:
Fluphenazine
Fluphenazine depot
Fluphenazine enanthate